
Palatin Technologies, Inc. Common Stock
PTN · NASDAQ · Healthcare / Biotechnology
Price History
Full chartMarket Stats
About
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Carl Spana Ph.D.
- Employees29
- Headquarters11 Deer Park Drive, Monmouth Junction, NJ, United States, 08512, USA
- Websitehttps://palatin.com
Leadership
- Dr. Carl Spana Ph.D.Co-Founder, President, CEO & Director · b. 1962
- Mr. Stephen T. Wills CPA, MSTCFO, COO, Executive VP, Treasurer & Secretary · b. 1957
- Burns McClellanVice President of Investor Relations
- Mr. Stephen A. Slusher Esq.Chief Legal Officer
- Mr. James E. Hattersley B.A., M.S.Senior Vice President of Business Development · b. 1960
- Mr. John Dodd Ph.D.Senior Vice President of Preclinical Development
- Mr. Robert JordanSenior Vice President of Program Operations
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Buy1
Ownership Breakdown
- Institutions
- 50.16%
- Insiders
- 7.86%
- Retail / Other
- 41.98%
Top Institutional Holders
- Driehaus Capital Management LLC166.71K9.37%
- HHG PLC140.00K7.87%
- Logos Global Management LP130.00K7.31%
- RA Capital Management, LLC70.00K3.93%
- Balyasny Asset Management LLC41.17K2.31%
- Morgan Stanley - Brokerage Accounts27.27K1.53%
- Opaleye Management Inc20.50K1.15%
- Vanguard Capital Management, LLC18.98K1.07%
- Geode Capital Management, LLC18.50K1.04%
- Miller Financial Services LLC15.00K0.84%
- LPL Financial Corp12.55K0.71%
- Vanguard Fiduciary Trust Co8.77K0.49%
- UBS Group AG3.33K0.19%
- Vanguard Global Advisers, LLC1.25K0.07%
Top Fund Holders
- Fidelity Extended Market Index9.15K0.51%
- iShares Micro-Cap ETF5.28K0.30%
- Fidelity Total Market Index3.12K0.18%
- Fidelity Series Total Market Index2.62K0.15%
- Fidelity Nasdaq Composite Index1.97K0.11%
- Vanguard U.S. Eq Idx £ Acc1.25K0.07%
Stock Splits
- Aug 12, 20251:50
- Aug 31, 20221:25
- Sep 27, 20101:10